Adam Lowy

1.4k total citations
20 papers, 874 citations indexed

About

Adam Lowy is a scholar working on Molecular Biology, Oncology and Economics and Econometrics. According to data from OpenAlex, Adam Lowy has authored 20 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Economics and Econometrics. Recurrent topics in Adam Lowy's work include Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). Adam Lowy is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). Adam Lowy collaborates with scholars based in Switzerland, United States and United Kingdom. Adam Lowy's co-authors include Richard Herrmann, Luigi Terracciano, Christoph Rochlitz, Michelle Kramer, Lisa Ford, Pilar Lim, Mariëlle Eerdekens, Stephen R. Marder, U Metzger and Betsy Kohler and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Development.

In The Last Decade

Adam Lowy

20 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Lowy Switzerland 16 246 241 193 87 84 20 874
Nathan Brand United States 15 300 1.2× 183 0.8× 300 1.6× 39 0.4× 61 0.7× 44 1.1k
Terje Risberg Norway 23 138 0.6× 695 2.9× 285 1.5× 40 0.5× 54 0.6× 52 1.6k
Zhongyun Zhao United States 21 263 1.1× 527 2.2× 151 0.8× 77 0.9× 26 0.3× 77 1.2k
Jonathan R. Korn United States 17 118 0.5× 141 0.6× 96 0.5× 55 0.6× 26 0.3× 37 855
Amy Mulick United Kingdom 21 99 0.4× 262 1.1× 202 1.0× 96 1.1× 173 2.1× 55 1.5k
Joseph F. O’Donnell United States 13 67 0.3× 199 0.8× 88 0.5× 22 0.3× 28 0.3× 29 975
Markus C. Elze United Kingdom 13 62 0.3× 73 0.3× 162 0.8× 56 0.6× 51 0.6× 22 943
Stefan N. Symeonides United Kingdom 19 101 0.4× 898 3.7× 218 1.1× 86 1.0× 55 0.7× 58 1.4k
Kathleen Herkommer Germany 21 138 0.6× 241 1.0× 185 1.0× 36 0.4× 35 0.4× 96 1.2k
Corien Eeltink Netherlands 17 60 0.2× 376 1.6× 148 0.8× 102 1.2× 40 0.5× 40 848

Countries citing papers authored by Adam Lowy

Since Specialization
Citations

This map shows the geographic impact of Adam Lowy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Lowy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Lowy more than expected).

Fields of papers citing papers by Adam Lowy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Lowy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Lowy. The network helps show where Adam Lowy may publish in the future.

Co-authorship network of co-authors of Adam Lowy

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Lowy. A scholar is included among the top collaborators of Adam Lowy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Lowy. Adam Lowy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kario, Kazuomi, Adam Lowy, Veronica C. Munk, & Lieven Annemans. (2009). 24-Hour Blood Pressure Control – A Predictor for Clinical Outcomes. Current Hypertension Reviews. 5(2). 102–122. 5 indexed citations
2.
Young, Allan H., Dan A. Oren, Adam Lowy, et al.. (2008). Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. The British Journal of Psychiatry. 194(1). 40–48. 82 indexed citations
3.
Wang, Jixian, et al.. (2008). Missing item imputation for quality‐of‐life instruments with application to asthma quality‐of‐life questionnaires. Pharmaceutical Statistics. 8(1). 73–83. 1 indexed citations
4.
Marder, Stephen R., Michelle Kramer, Lisa Ford, et al.. (2007). Efficacy and Safety of Paliperidone Extended-Release Tablets: Results of a 6-Week, Randomized, Placebo-Controlled Study. Biological Psychiatry. 62(12). 1363–1370. 177 indexed citations
5.
Renzulli, Pietro, Adam Lowy, Rudolf Maibach, et al.. (2006). The influence of the surgeon’s and the hospital’s caseload on survival and local recurrence after colorectal cancer surgery. Surgery. 139(3). 296–304. 38 indexed citations
6.
7.
Bernhard, Jürg, et al.. (2004). Health related quality of life: A changing construct?. Quality of Life Research. 13(7). 1187–1197. 35 indexed citations
8.
Lowy, Adam & Jürg Bernhard. (2004). Quantitative assessment of changes in patients' constructs of quality of life: An application of multilevel models. Quality of Life Research. 13(7). 1177–1185. 17 indexed citations
9.
Dedes, Konstantin J., Thomas D. Szucs, Stephan Bodis, et al.. (2004). Management and Costs of Treating Lung Cancer Patients in a University Hospital. PharmacoEconomics. 22(7). 435–444. 38 indexed citations
10.
Schwenkglenks, Matthias, et al.. (2003). Costs of Asthma in a Cohort of Swiss Adults: Associations with Exacerbation Status and Severity. Value in Health. 6(1). 75–83. 27 indexed citations
11.
Boulay, Jean‐Louis, Gabriele Mild, Adam Lowy, et al.. (2003). SMAD7 is a prognostic marker in patients with colorectal cancer. International Journal of Cancer. 104(4). 446–449. 80 indexed citations
12.
Jantscheff, Peter, Luigi Terracciano, Adam Lowy, et al.. (2003). Expression of CEACAM6 in Resectable Colorectal Cancer: A Factor of Independent Prognostic Significance. Journal of Clinical Oncology. 21(19). 3638–3646. 136 indexed citations
13.
Mild, Gabriele, Felix Bachmann, Jean‐Louis Boulay, et al.. (2002). DCR3 locus is a predictive marker for 5‐fluorouracil‐based adjuvant chemotherapy in colorectal cancer. International Journal of Cancer. 102(3). 254–257. 31 indexed citations
14.
Boulay, Jean‐Louis, Gabriele Mild, Luigi Terracciano, et al.. (2001). Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7. Genes Chromosomes and Cancer. 31(3). 240–247. 25 indexed citations
15.
Lowy, Adam, Betsy Kohler, & Jon Nicholl. (1994). Attendance at accident and emergency departments: unnecessary or inappropriate?. Journal of Public Health. 16(2). 134–140. 66 indexed citations
16.
Lowy, Adam, K L Woods, & J. L. Botha. (1991). The effects of demographic shift on coronary heart disease mortality in a large migrant population at high risk. Journal of Public Health. 13(4). 276–80. 10 indexed citations
17.
Lowy, Adam, Jeffrey A. Drebin, John G. Monroe, Richard D. Granstein, & Mark I. Greene. (1984). Genetically restricted antigen presentation for immunological tolerance and suppression. Nature. 308(5957). 373–375. 38 indexed citations
18.
Monroe, John G., Adam Lowy, Richard D. Granstein, & Mark I. Greene. (1984). Studies of Immune Responsiveness and Unresponsiveness to the p‐Azobenzenearsonate (ABA) Hapten. Immunological Reviews. 80(1). 103–131. 18 indexed citations
19.
Tominaga, Akira, Sophie Lefort, Steven B. Mizel, et al.. (1983). Molecular signals in antigen presentation. Clinical Immunology and Immunopathology. 29(2). 282–293. 20 indexed citations
20.
Beck, Felix & Adam Lowy. (1982). The effect of cathepsin inhibitor on rat embryos grownin vitro. Development. 71(1). 1–9. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathan Brand Breakdown of academic impact, for papers by Terje Risberg Breakdown of academic impact, for papers by Zhongyun Zhao Breakdown of academic impact, for papers by Jonathan R. Korn Breakdown of academic impact, for papers by Amy Mulick Breakdown of academic impact, for papers by Joseph F. O’Donnell Breakdown of academic impact, for papers by Markus C. Elze Breakdown of academic impact, for papers by Stefan N. Symeonides Breakdown of academic impact, for papers by Kathleen Herkommer Breakdown of academic impact, for papers by Corien Eeltink
Rankless by CCL
2026